THOP1 was required, either together with nardilysin or alone, for the generation of a tumor-specific CTL epitope from PRAME, an immunodominant CTL epitope from Epstein–Barr virus protein EBNA3C, and a clinically important epitope from the melanoma protein MART-1 [38]. This evidence concerns the gene THOP1 and melanoma.